KROS: Keros Therapeutics Inc

14.41 USD 0.25 (1.71%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de KROS de hoy ha cambiado un -1.71%. En este caso, el precio mínimo en el mercado ha alcanzado 14.35, mientras que el máximo ha alcanzado 14.80.

Siga la dinámica de la pareja de divisas Keros Therapeutics Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

KROS News

Zacks 15:40 KROS vs. EXAS: Which Stock Should Value Investors Buy Now?
Zacks 14:54 Will Reblozyl Enable BMY to Offset the Impact of Generic Competition?
Seeking Alpha 13:50 ClearBridge Small Cap Strategy Q2 2025 Commentary
Zacks 15:28 RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure
Zacks 14:39 FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
Investing 12:05 Keros Therapeutics doses first patient in Phase 3 MDS trial
Reuters 14:41 Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Benzinga 18:37 Keros Therapeutics' Quiet Near-Term Outlook Overshadows Pipeline Potential: Analyst - Keros Therapeutics (NASDAQ:KROS)
Investing 09:05 BofA cuts Keros Therapeutics stock rating, price target to $18
Investing 19:17 Keros directors face significant shareholder dissent
Investing 11:01 Keros Therapeutics to return $375 million to shareholders
Investing 20:16 Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
Benzinga 16:54 Keros Therapeutics Stops PAH Drug Development, Shrinks Workforce By 45% - Keros Therapeutics (NASDAQ:KROS)
Investing 10:57 Keros Therapeutics halts PAH drug development, cuts workforce
Investing 17:48 Keros secures Glass Lewis support for director nominees
Investing 12:14 ADAR1 calls for Keros to release review results before vote
Investing 12:28 Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
Seeking Alpha 18:13 Keros Therapeutics (KROS): Strategic Alternatives Could Bring About Value Creation
Benzinga 17:51 Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan - Keros Therapeutics (NASDAQ:KROS)
Benzinga 16:12 Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - CarMax (NYSE:KMX), Keros Therapeutics (NASDAQ:KROS)
Benzinga 14:05 PriceSmart Posts Better-Than-Expected Earnings, Joins Enact Holdings, DexCom And Other Big Stocks Moving Higher On Thursday - Enact Holdings (NASDAQ:ACT), DexCom (NASDAQ:DXCM)
Seeking Alpha 22:25 Keros Therapeutics: Losing Its Lead Drug Is Bad Medicine (NASDAQ:KROS)
Seeking Alpha 14:01 Fidelity Select Health Care Portfolio Q4 2024 Review (Mutual Fund:FSPHX)

Rango diario

14.35 14.80

Rango anual

9.12 72.37

Cierres anteriores: 14.48
Open: 14.66

Bid: 14.41
Ask: 14.71

Low: 14.35
High: 14.80

Volumen: 812

Cambio diario: -1.71%
Cambio mensual: 8.18%

Cambio a 6 meses: 29.59%
Cambio anual: -71.40%

30 julio, miércoles